ÂÜÀòÂÒÂ×

Collin Smith is an experienced professional in the clinical research field, currently serving as a Study Start Up Associate I at ICON plc since July 2022 and as Founder & Chief Executive Officer of Rapidemia since June 2023. Prior roles include In-House Clinical Research Associate at ICON plc, Clinical Research Coordinator at Virginia Eye Consultants, and Clinical Research Coordinator at Meridian Clinical Research, where responsibilities encompassed managing multiple trials, training new coordinators, and ensuring compliance with study protocols. Earlier experience includes serving as a Quality Assurance and Regulatory Affairs Intern at LifeNet Health, where duties involved data analysis and regulatory filing. Collin holds a Bachelor of Science in Neuroscience from Virginia Tech and a high school diploma from Cape Henry Collegiate.